AGL 39.58 Decreased By ▼ -0.42 (-1.05%)
AIRLINK 131.22 Increased By ▲ 2.16 (1.67%)
BOP 6.81 Increased By ▲ 0.06 (0.89%)
CNERGY 4.71 Increased By ▲ 0.22 (4.9%)
DCL 8.44 Decreased By ▼ -0.11 (-1.29%)
DFML 41.47 Increased By ▲ 0.65 (1.59%)
DGKC 82.09 Increased By ▲ 1.13 (1.4%)
FCCL 33.10 Increased By ▲ 0.33 (1.01%)
FFBL 72.87 Decreased By ▼ -1.56 (-2.1%)
FFL 12.26 Increased By ▲ 0.52 (4.43%)
HUBC 110.74 Increased By ▲ 1.16 (1.06%)
HUMNL 14.51 Increased By ▲ 0.76 (5.53%)
KEL 5.19 Decreased By ▼ -0.12 (-2.26%)
KOSM 7.61 Decreased By ▼ -0.11 (-1.42%)
MLCF 38.90 Increased By ▲ 0.30 (0.78%)
NBP 64.01 Increased By ▲ 0.50 (0.79%)
OGDC 192.82 Decreased By ▼ -1.87 (-0.96%)
PAEL 25.68 Decreased By ▼ -0.03 (-0.12%)
PIBTL 7.34 Decreased By ▼ -0.05 (-0.68%)
PPL 154.07 Decreased By ▼ -1.38 (-0.89%)
PRL 25.83 Increased By ▲ 0.04 (0.16%)
PTC 17.81 Increased By ▲ 0.31 (1.77%)
SEARL 82.30 Increased By ▲ 3.65 (4.64%)
TELE 7.76 Decreased By ▼ -0.10 (-1.27%)
TOMCL 33.46 Decreased By ▼ -0.27 (-0.8%)
TPLP 8.49 Increased By ▲ 0.09 (1.07%)
TREET 16.62 Increased By ▲ 0.35 (2.15%)
TRG 57.40 Decreased By ▼ -0.82 (-1.41%)
UNITY 27.51 Increased By ▲ 0.02 (0.07%)
WTL 1.37 Decreased By ▼ -0.02 (-1.44%)
BR100 10,504 Increased By 59.3 (0.57%)
BR30 31,226 Increased By 36.9 (0.12%)
KSE100 98,080 Increased By 281.6 (0.29%)
KSE30 30,559 Increased By 78 (0.26%)

A South Korean court Monday imposed a suspended prison term on a disgraced scientist whose claims of stem-cell breakthroughs rocked the scientific world until his research was found to be faked. The Seoul court passed a two-year sentence suspended for three years on Hwang Woo-Suk after convicting him of embezzling research funds and of ethical lapses in obtaining human eggs for experiments.
It found him not guilty of defrauding private entities that contributed funds to his research. Prosecutors had demanded a four-year jail term for Hwang, who went on trial in June 2006, and said they would appeal the ruling that he is not guilty of fraud. Judges said he had known that his team "exaggerated or manipulated" some experiments, although they found no evidence he directly instructed them to do so.
The 56-year-old Hwang, who was impassive as the verdict was read, still retains a loyal following. He later smiled and shook hands with supporters inside the courtroom who clapped and shouted "Doctor Hwang, cheer up!" Another crowd of about 100 supporters outside applauded Hwang as he walked out through a crowd of journalists. The court received petitions from 55 lawmakers and others calling for leniency.
The scientist said his lawyers would decide whether to appeal. Hwang shot to fame in 2004 when he published a paper in the US journal "Science" claiming to have created the world's first stem-cell line from a cloned human embryo. In a follow-up paper in 2005 in the same journal, he maintained that his team had developed 11 patient-specific embryonic stem-cell lines. The claims raised hopes of new treatments for diseases such as cancer, diabetes and Parkinson's.
The government showered Hwang and his team from the prestigious Seoul National University (SNU) with money and honours. Hwang was awarded the title of "Supreme Scientist". But his reputation was tarnished in November 2005 by allegations that he had violated medical ethics by accepting human eggs from his own researchers.
Hwang apologised for the lapse but the scandal widened with reports from local television network MBC that his entire research was fabricated. In January 2006 an SNU investigative team ruled in a report that his findings were faked and said he had produced no stem cells of any kind.
Hwang was also found guilty of breaching a law on bioethics which bans illegal human egg transactions. "Hwang and his team failed to prove that they were not involved in illegal trading of human eggs," the verdict said. The judges said Hwang had misappropriated a combined 830 million won (704,000 dollars) in research funds by using borrowed bank accounts or manipulating tax bills. But they said he did not do so for personal profit.

Copyright Agence France-Presse, 2009

Comments

Comments are closed.